Table 4.

Risk of complications related to inflammatory bowel disease (IBD) in patients with eosinophilic esophagitis (EoE) versus without EoE

	HR (95% CI)	p values	aHR* (95% CI) (after matching)	p values
Crohn’s Disease			(n = 1844)
Glucocorticoid	1.344 (1.249, 1.446)	< 0.0001	1.045 (0.943, 1.159)	0.4007
Biologic therapy	1.764 (1.627, 1.911)	< 0.0001	1.184 (1.054, 1.329)	0.0042
Abdominal surgery	0.957 (0.759, 1.207)	0.7131	0.948 (0.691, 1.3)	0.7381
Composite	1.478 (1.389, 1.572)	< 0.0001	1.137 (1.04, 1.242)	0.0046
Ulcerative Colitis			(n = 1152)
Glucocorticoid	1.403 (1.282, 1.535)	< 0.0001	1.107 (0.972, 1.26)	0.123
Biologic therapy	1.929 (1.723, 2.16)	< 0.0001	1.132 (0.962, 1.333)	0.1345
Abdominal surgery	1.014 (0.716, 1.436)	0.9369	0.846 (0.528, 1.355)	0.4854
			NA
Composite	1.54 (1.423, 1.667)	< 0.0001	1.166 (1.039, 1.307)	0.0086

*Propensity matched data

CI: confidence interval; HR: hazard ratio; aHR: adjusted hazard ratio